Clinical outcome of 149 patients with polymyalgia rheumatica and giant cell arteritis

Journal of Rheumatology

Volumn 25, Issue 1, 1998, Pages 99-104

  Bahlas, Sami ^a   Ramos Remus, Cesar ^a,b   Davis, Paul ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF GUADALAJARA   (Mexico)

Author keywords

Giant cell arteritis; Outcome; Polymyaglia rheumatica

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE;

ADULT; AGED; ARTICLE; BLINDNESS; CANCER; CATARACT; CLINICAL FEATURE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE DURATION; FEMALE; FRACTURE; GIANT CELL ARTERITIS; HUMAN; HYPERTENSION; INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REMISSION; RHEUMATIC POLYMYALGIA; RHEUMATOID ARTHRITIS; STEROID THERAPY; SYNOVITIS; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; ANTIMETABOLITES, ANTINEOPLASTIC; FEMALE; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); POLYMYALGIA RHEUMATICA; PREDNISONE; TEMPORAL ARTERITIS;

EID: 0031975936     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Myles AB. Polymyalgia rheumatica and giant cell arteritis: A seven year survey. Rheumatol Rehabil 1975;14:231-5.
2. Behn AR, Perera T, Myles AB. Polymyalgia rheumatica and corticosteroids: How much for how long? Ann Rheum Dis 1983;42:374-8.
3. Delecoeuillerie J, Joly P, Cohen De Lara A, Paolaggi JB. Polymyalgia rheumatica and temporal arteritis: A retrospective analysis of prognostic features and different corticosteroid regimens (11 year survey of 210 patients). Ann Rheum Dis 1988;47:733-9.
4. Nordborg E, Nordborg C. The influence of sectional interval on the reliability of temporal arterial biopsies in polymyalgia rheumatica. Clin Rheumatol 1995;14:330-4.
5. Jones JG, Hazleman BL. Prognosis and management of polymyalgia rheumatica. Ann Rheum Dis 1981;40:1-5.
6. Sheehan NJ, Myles AB. Occurrence of polymyalgia rheumatica in rheumatoid arthritis [letter]. BMJ 1986;292:1394-5.
7. Dimont J. Rheumatoid arthritis in the elderly, presenting as polymyalgia rheumatica. J Am Geriatr Soc 1979;27:183-5.
8. Weinberger KA. Rheumatoid arthritis masquerading as polymyalgia rheumatica: Report of 2 cases. J Am Geriatr Soc 1980;28:523-4.
9. Horsley-Peterson K, Helin P. Coexistence of temporal arteritis and rheumatoid arthritis. J Rheumatol 1983;10:831-2.
10. Bird HA, Esselinckx W, Dixon AStJ, Mowat AG, Wood PHN. An evaluation of criteria for polymyalgia rheumatica. Ann Rheum Dis 1979;38:434-9.
11. Cohen MD, Ginsberg WW. Polymyalgia rheumatica. Rheum Dis Clin North Am 1990;16:325-39.
12. Hamrin B. Polymyalgia rheumatica. Acta Med Scand 1972;Suppl 533:1-164.
13. Miller LD, Stevens MB. Skeletal manifestations of polymyalgia rheumatica. JAMA 1978;240:27-9.
14. Al-Hussaini AS, Swannell AJ. Peripheral joint involvement in polymyalgia rheumatica: A clinical study of 56 cases. Br J Rheumatol 1985;24:27-30.
15. Healey LA. Long-term follow-up of polymyalgia rheumatica: Evidence for synovitis. Semin Arthritis Rheum 1984;13:322-8.
16. Henderson DRF, Tribe CR, Dixon AStJ. Synovitis in polymyalgia rheumatica. Rheumatol Rehabil 1975;14:244-50.
17. Helfgott SM, Kieval RI. Polymyalgia rheumatica in patients with a normal erythrocyte sedimentation rate. Arthritis Rheum 1996;39:304-7.
18. Ellis ME, Ralston S. The ESR in the diagnosis and management of the polymyalgia rheumatica/giant cell arteritis syndrome. Ann Rheum Dis 1983;42:168-70.
19. Sueiro JLF, Armona J, Rodriguez-Valverde V, Blanco R, Taboada MM. Polymyalgia rheumatica without clinically significant increased ESR [abstract]. Arthritis Rheum 1994;37 Suppl:S410.
20. Kyle V, Cawston TE, Hazleman B. Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during followup. Ann Rheum Dis 1989;48:667-71.
21. Paulley JW, Hughes JP. Giant cell arteritis, or arteritis of the aged. BMJ 1960;2:1562-7.
22. Huston KA, Hunder GG, Lie JT, Kennedy RH, Elveback LR. Temporal arteritis. A 25 year epidemiological, clinical and pathological study. Ann Intern Med 1978;88:162-7.
23. Chaung T-Y, Hunder GG, Ilstrup DM, Kurland LT. Polymyalgia rheumatica. A 10 year epidemiologic and clinical study. Ann Intern Med 1982;97:672-80.
24. Park JR, Jones JG, Hazleman BL. Relationship of erythrocyte sedimentation rate to acute phase proteins in polymyalgia rheumatica and giant cell arteritis. Ann Rheum Dis 1981;40:493-5.
25. Mallya RK, Hind CRK, Berry H, Pepys MB. Serum C-reactive protein in polymyalgia rheumatica. Arthritis Rheum 1985;28:383-7.
26. Esselinckx W, Bucknall RC, Dixon AS. Polymyalgia rheumatica: Assessment of disease activity using erythrocyte sedimentation rate and plasma viscosity. Ann Rheum Dis 1977;36:560-2.
27. Mowt AG. Generalised rheumatism: Polymyalgia rheumatica and its differential diagnosis. Clin Rheum Dis 1979;5:775-95.
28. Catoggio LJ, Soriano ER, Imamura PM. Treatment of polymyalgia rheumatica: Lower initial dose [letter]. Br J Rheumatol 1991;30:393-4.
29. Kyle V, Hazleman BL. Treatment of polymyalgia rheumatica and giant cell arteritis. I. Steroid regimens in the first two months. Ann Rheum Dis 1989;48:658-61.
30. Kogstad OA. Polymyalgia rheumatica and its relation to arteritis temporalis. Acta Med Scand 1965;178:591-8.
31. Huston KA, Hunder GG. Giant cell arteritis: A clinical review. Am Heart J 1980;100:99-107.
32. Gonzalez-Gay MA, Santiago J, Monte R, Blanco R. Low-dose corticosteroids and blindness in giant cell arteritis [letter]. Br J Rheumatol 1996;35:702-3.
33. Aiello PD, Trautmann JC, McPhee TJ, Kunselman AR, Hunder GG. Visual prognosis in giant cell arteritis. Ophthalmology 1993;100:550-5.
34. Laidlaw DAH, Blomm PA, Williams C, Easty DL. Steroid treatment in giant cell arteritis. Br J Rheumatol 1992;31:431-2.
35. Ferraccioli G, Salaffi F, De Vita S, Casatta L, Bartoli E. Methotrexate in polymyalgia rheumatica: Preliminary results of an open, randomized study. J Rheumatol 1996;23:624-8.
36. De Silva M, Hazleman BL. Azathioprine in giant cell arteritis/polymyalgia rheumatica: A double blind study. Ann Rheum Dis 1986;45:136-8.
37. Salvarani C, Macchioni PL, Tartoni PL, et al. Polymyalgia rheumatica and giant cell arteritis: A 5 year epidemiologic and clinical study in Reggio Emilia, Italy. Clin Exp Rheumatol 1987;5:205-15.
38. Healey LA. Polymyalgia rheumatica and seronegative rheumatoid arthritis may be the same entity. J Rheumatol 1992;19:270-2.
39. Healey LA, Sheets PK. The relation of polymyalgia rheumatica to rheumatoid arthritis. J Rheumatol 1988;15:750-2.
40. Deal CL, Meenan RF, Goldenberg DL, et al. The clinical features of elderly-onset rheumatoid arthritis. Arthritis Rheum 1985;28:987-94.
41. Calin A, Marks SH. The case against seronegative rheumatoid arthritis. Am J Med 1981;70:992-4.